In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.

March 13 () - A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from the same class of ...

To receive coverage for Xarelto, a person must be enrolled in a Medicare Part D prescription drug plan or a Medicare Advantage (Part C) plan that includes prescription drug coverage. This article ...

Rivaroxaban for oral suspension, 1 mg/ml (RLD Xarelto) had a market value of roughly $11 million, per IQVIA July 2025 data. Lupin has received approval from the Food and Drug Administration for ...

The FDA approved Johnson & Johnson and Bayer’s anti-clotting drug Xarelto for the treatment of atrial fibrillation, according to a CBS News report. The makers of Xarelto wanted the FDA to approve a ...

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear ...

For many of us, Thursday was Health-Policy-Wonk Festivus. The Centers for Medicare & Medicaid Services released the Maximum Fair Prices (MFPs) for the first 10 drugs subject to negotiation under the ...

Sandoz is introducing generic rivaroxaban in Germany, in new generic strengths of 10 mg, 15 mg and 20 mg. Rivaroxaban - 1 A Pharma is a generic of Bayer Intellectual Property GmbH’s Xarelto. Sandoz ...

NEW YORK, Feb 14 (Reuters) - U.S. health regulators have again declined to approve proposed wider uses of Bayer AG and Johnson & Johnson's lucrative blood clot preventer Xarelto, the drugmakers said ...